In Segment A, members will receive diverse doses and schedules of oral ABBV-744 pill to establish Secure dosing regimen. Extra individuals is going to be enrolled at the identified monotherapy dosign regimen. In Segment B, individuals will receive oral ruxolitinib and ABBV-744 might be specified as "add-on" therapy. In Segment https://remingtonxiteq.tkzblog.com/31931135/details-fiction-and-abbv-744-in-acute-myeloid-leukemia-aml